Liquidia Corp (LQDA)
12.74
+0.45
(+3.66%)
USD |
NASDAQ |
May 16, 16:00
12.72
-0.02
(-0.12%)
After-Hours: 20:00
Liquidia Cash from Financing (Quarterly): 99.67M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.67M |
| December 31, 2023 | 23.64M |
| September 30, 2023 | 10.06M |
| June 30, 2023 | -0.409M |
| March 31, 2023 | 9.95M |
| December 31, 2022 | 0.057M |
| September 30, 2022 | 0.348M |
| June 30, 2022 | 54.48M |
| March 31, 2022 | 10.08M |
| December 31, 2021 | 1.019M |
| September 30, 2021 | 1.995M |
| June 30, 2021 | 22.55M |
| March 31, 2021 | 0.759M |
| December 31, 2020 | -1.108M |
| September 30, 2020 | 68.60M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.024M |
| March 31, 2020 | -1.048M |
| December 31, 2019 | 30.69M |
| September 30, 2019 | -0.2279M |
| June 30, 2019 | 4.307M |
| March 31, 2019 | 31.63M |
| December 31, 2018 | 0.4488M |
| September 30, 2018 | 44.70M |
| June 30, 2018 | -0.7674M |
| March 31, 2018 | 24.43M |
| December 31, 2017 | 3.886M |
| September 30, 2017 | 9.312M |
| June 30, 2017 | -0.087M |
| March 31, 2017 | 15.70M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.024M
Minimum
Jun 2020
99.67M
Maximum
Mar 2024
16.62M
Average
3.151M
Median
Cash from Financing (Quarterly) Benchmarks
| United Therapeutics Corp | -1.068B |
| AIM ImmunoTech Inc | 0.147M |
| Perspective Therapeutics Inc | 0.352M |
| Protalix BioTherapeutics Inc | 0.00 |
| Armata Pharmaceuticals Inc | 34.93M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -24.87M |
| Cash from Investing (Quarterly) | -0.624M |
| Free Cash Flow | -69.52M |
| Free Cash Flow Per Share (Quarterly) | -0.3381 |
| Free Cash Flow to Equity (Quarterly) | -25.49M |
| Free Cash Flow Yield | -8.06% |